[Generalized anxiety disorders (GAD)--a neglected illness? Background und aims of the GAD-P study]

Fortschr Med Orig. 2001:119 Suppl 1:1-4.
[Article in German]

Abstract

In the past Generalized anxiety disorder (GAD)--previously classified as anxiety neurosis--was regarded as not being a separate diagnostic entity. On the basis of new explicit criteria for GAD in the 90ies, GAD-specific pharmacological (i.e. SNRI) and psychological treatments with improved efficacy have become available. The Generalized Anxiety and Depression in Primary care study (GAD-P) investigates the prevalence of GAD in primary care settings and evaluates the patterns of care provided. Aims, methods and findings of the GAD-P study are described in this supplement.

Publication types

  • Comparative Study
  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Anxiety Agents / therapeutic use
  • Antidepressive Agents, Second-Generation / therapeutic use
  • Anxiety Disorders* / diagnosis
  • Anxiety Disorders* / epidemiology
  • Anxiety Disorders* / therapy
  • Cyclohexanols / therapeutic use
  • Diagnosis, Differential
  • Humans
  • Middle Aged
  • Prevalence
  • Primary Health Care
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Surveys and Questionnaires
  • Venlafaxine Hydrochloride

Substances

  • Anti-Anxiety Agents
  • Antidepressive Agents, Second-Generation
  • Cyclohexanols
  • Serotonin Uptake Inhibitors
  • Venlafaxine Hydrochloride